(Q50941259)

English

Microbiological etiology and susceptibility of bacterial conjunctivitis isolates from clinical trials with ophthalmic, twice-daily besifloxacin

scientific article published on 25 May 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/22644963

Microbiological etiology and susceptibility of bacterial conjunctivitis isolates from clinical trials with ophthalmic, twice-daily besifloxacin (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/22644963

bacterial conjunctivitis

1 reference

based on heuristic

inferred from title

author name string

Wolfgang Haas

1

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/22644963

Lynne S Gearinger

2

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/22644963

Christine K Hesje

3

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/22644963

Christine M Sanfilippo

4

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/22644963

Timothy W Morris

5

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/22644963

language of work or name

0 references

publication date

25 May 2012

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/22644963

Advances in Therapy

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/22644963

29

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/22644963

5

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/22644963

442-455

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/22644963

Acute conjunctivitis: truth and misconceptions

1 reference

https://api.crossref.org/works/10.1007%2FS12325-012-0023-Y

21 January 2018

Acute bacterial conjunctivitis

1 reference

https://api.crossref.org/works/10.1007%2FS12325-012-0023-Y

21 January 2018

Bacterial conjunctivitis in children: a current review of pathogens and treatment.

1 reference

https://api.crossref.org/works/10.1007%2FS12325-012-0023-Y

21 January 2018

Ocular TRUST: nationwide antimicrobial susceptibility patterns in ocular isolates.

1 reference

https://api.crossref.org/works/10.1007%2FS12325-012-0023-Y

21 January 2018

Update on bacterial conjunctivitis in South Florida.

1 reference

https://api.crossref.org/works/10.1007%2FS12325-012-0023-Y

21 January 2018

Besifloxacin: a novel anti-infective for the treatment of bacterial conjunctivitis

1 reference

https://api.crossref.org/works/10.1007%2FS12325-012-0023-Y

21 January 2018

Besifloxacin ophthalmic suspension 0.6%.

1 reference

https://api.crossref.org/works/10.1007%2FS12325-012-0023-Y

21 January 2018

Besifloxacin, a new ophthalmic fluoroquinolone for the treatment of bacterial conjunctivitis

1 reference

https://api.crossref.org/works/10.1007%2FS12325-012-0023-Y

21 January 2018

Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria

1 reference

https://api.crossref.org/works/10.1007%2FS12325-012-0023-Y

21 January 2018

Bactericidal activity of besifloxacin against staphylococci, Streptococcus pneumoniae and Haemophilus influenzae

1 reference

https://api.crossref.org/works/10.1007%2FS12325-012-0023-Y

21 January 2018

Efficacy and safety of besifloxacin ophthalmic suspension 0.6% compared with moxifloxacin ophthalmic solution 0.5% for treating bacterial conjunctivitis.

1 reference

https://api.crossref.org/works/10.1007%2FS12325-012-0023-Y

21 January 2018

Besifloxacin ophthalmic suspension 0.6% in patients with bacterial conjunctivitis: A multicenter, prospective, randomized, double-masked, vehicle-controlled, 5-day efficacy and safety study

1 reference

https://api.crossref.org/works/10.1007%2FS12325-012-0023-Y

21 January 2018

Efficacy and tolerability of besifloxacin ophthalmic suspension 0.6% administered twice daily for 3 days in the treatment of bacterial conjunctivitis: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study in adults and c

1 reference

https://api.crossref.org/works/10.1007%2FS12325-012-0023-Y

21 January 2018

Topical tobramycin and gentamicin sulfate in the treatment of ocular infections: multicenter study

1 reference

https://api.crossref.org/works/10.1007%2FS12325-012-0023-Y

21 January 2018

Shifting trends in in vitro antibiotic susceptibilities for common bacterial conjunctival isolates in the last decade at the New York Eye and Ear Infirmary

1 reference

https://api.crossref.org/works/10.1007%2FS12325-012-0023-Y

21 January 2018

An outbreak of conjunctivitis due to atypical Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1007%2FS12325-012-0023-Y

21 January 2018

Phenotypic and phylogenetic characterization of some Gemella-like organisms from human infections: description of Dolosigranulum pigrum gen. nov., sp. nov.

1 reference

https://api.crossref.org/works/10.1007%2FS12325-012-0023-Y

21 January 2018

Antimicrobial susceptibility and clinical sources of Dolosigranulum pigrum cultures

1 reference

https://api.crossref.org/works/10.1007%2FS12325-012-0023-Y

21 January 2018

Diversity of bacteria at healthy human conjunctiva

1 reference

https://api.crossref.org/works/10.1007%2FS12325-012-0023-Y

21 January 2018

Impact of antibiotic resistance in the management of ocular infections: the role of current and future antibiotics

1 reference

https://api.crossref.org/works/10.1007%2FS12325-012-0023-Y

21 January 2018

Identifiers

10.1007/S12325-012-0023-Y

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/22644963

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/22644963

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50941259&oldid=2263610122"